Table 5 Summary information on recruited patients developing elevated PSA levels
From: A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer
BRCA1 −ve | BRCA1 +ve | BRCA2 −ve | BRCA2 +ve | Lynch −ve | Lynch +ve | |
|---|---|---|---|---|---|---|
Total number | 7 | 7 | 12 | 20 | 0 | 4 |
Number with elevated PSA | 1 | 1 | 3 | 1 | 0 | 1 |
Number undergoing biopsies | 1 | 1 | 3 | 1 | 0 | 1 |
+ve prostate cancer | 0 | 1 | 0 | 1 | 0 | 1 |